FDA Approved: SILENOR — Supplemental Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for SILENOR (doxepin hydrochloride) submitted by Currax Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Silenor (Doxepin hydrochloride)

Snippet

SUPPL AP for SILENOR (DOXEPIN HYDROCHLORIDE)